Michael G. Grey
Director · OnKure Therapeutics, Inc.
IndividualSelling only6 10b5-1 trades
- 2024
- Aug 11, 2026
- 11
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Michael G. Grey files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jason A. Leverone - $3K in OKUR purchases and sales in the last 12 months
- Nicholas A. Saccomano - $994 in OKUR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael G. Grey?
Michael G. Grey is a corporate insider, tracked as Director of OnKure Therapeutics, Inc. (OKUR). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Michael G. Grey submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Michael G. Grey been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($7.20M) across all tracked filings.
